Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTXBiotechnology
+$0.10 today
- Market cap
- $980.14M
- Beta
- 0.00
Volume 0.68M
Average 0.41M
SPTX EPS (Basic)
Net income attributable to common shareholders divided by the weighted average basic shares outstanding.
EPS (Basic) history
Currency unavailable · from the income statement
No EPS (Basic) data reported for this period type.
EPS (Basic) vs competitors
How SPTX compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | -$0.92 USD | -16.5% | — | |
NMRANeumora Therapeutics, Inc. Common Stock | LTM Mar 2026 | -$1.33 USD | +17.4% | — |
CTNMContineum Therapeutics, Inc. Class A Common Stock | LTM Mar 2026 | -$1.95 USD | -1.0% | — |
RAPPRapport Therapeutics, Inc. Common Stock | LTM Mar 2026 | -$2.6 USD | -15.6% | — |
| LTM Mar 2026 | -$4.05 USD | -437.5% | — | |
| LTM Mar 2026 | -$4.58 USD | -134.9% | — | |
LBRXLB Pharmaceuticals Inc Common Stock | LTM Mar 2026 | -$21.47 USD | — | — |
SPTXSeaport Therapeutics, Inc. Common Stock | — | — | — | — |
| Peer median (excluding SPTX) | — | -16.0% | — | |
Competitors are the stored peer set for SPTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTX
Intrinsic Alpha fair value
Locked
Current Price
$18.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.